Skip to main content
NCBI home page
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1992;70(2):173–182.

Prevention and control of neurofibromatosis: memorandum from a joint WHO/NNFF meeting.

PMCID: PMC2393308  PMID: 1600579

Abstract

Neurofibromatosis (NF) is a serious, common, genetically determined neurological disorder; with a prevalence of about 1:4000 births it affects both sexes and all races and ethnic groups. The two major forms are referred to as NF1 and NF2, as suggested in 1987 by a National Institutes of Health Consensus Development Conference on Neurofibromatosis. In NF1, the disease phenotype is more variable and complex than in NF2. Complications can occur in any of the body systems in tissues of ectodermal, mesodermal and neural tube origin; there is marked variation of disease phenotype even within families. The NF2 gene, in contrast, only seems to be expressed in tissues of ectodermal origin and its expression is more uniform both within and between families. The recent discovery and isolation of the gene responsible for the NF1 mutation has practical applications in the field of molecular genetics which could modify the approaches for diagnosis, treatment and prevention of NF. This Memorandum summarizes the discussions and recommendations of the participants at a joint WHO/National Neurofibromatosis Foundation (NNFF) meeting, held in Jacksonville, Florida, USA, on 27-28 January 1991.

Full text

PDF
173

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ballester R., Marchuk D., Boguski M., Saulino A., Letcher R., Wigler M., Collins F. The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell. 1990 Nov 16;63(4):851–859. doi: 10.1016/0092-8674(90)90151-4. [DOI] [PubMed] [Google Scholar]
  2. Barker D., Wright E., Nguyen K., Cannon L., Fain P., Goldgar D., Bishop D. T., Carey J., Baty B., Kivlin J. Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17. Science. 1987 May 29;236(4805):1100–1102. doi: 10.1126/science.3107130. [DOI] [PubMed] [Google Scholar]
  3. CROWE F. W. AXILLARY FRECKLING AS A DIAGNOSTIC AID IN NEUROFIBROMATOSIS. Ann Intern Med. 1964 Dec;61:1142–1143. doi: 10.7326/0003-4819-61-6-1142. [DOI] [PubMed] [Google Scholar]
  4. CROWE F. W., SCHULL W. J. Diagnostic importance of café-au-lait spot in neurofibromatosis. AMA Arch Intern Med. 1953 Jun;91(6):758–766. doi: 10.1001/archinte.1953.00240180067008. [DOI] [PubMed] [Google Scholar]
  5. Calzavara P. G., Carlino A., Anzola G. P., Pasolini M. P. Segmental neurofibromatosis. Case report and review of the literature. Neurofibromatosis. 1988;1(5-6):318–322. [PubMed] [Google Scholar]
  6. Carey J. C., Baty B. J., Johnson J. P., Morrison T., Skolnick M., Kivlin J. The genetic aspects of neurofibromatosis. Ann N Y Acad Sci. 1986;486:45–56. doi: 10.1111/j.1749-6632.1986.tb48061.x. [DOI] [PubMed] [Google Scholar]
  7. Cawthon R. M., Weiss R., Xu G. F., Viskochil D., Culver M., Stevens J., Robertson M., Dunn D., Gesteland R., O'Connell P. A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations. Cell. 1990 Jul 13;62(1):193–201. doi: 10.1016/0092-8674(90)90253-b. [DOI] [PubMed] [Google Scholar]
  8. Duffner P. K., Cohen M. E., Seidel F. G., Shucard D. W. The significance of MRI abnormalities in children with neurofibromatosis. Neurology. 1989 Mar;39(3):373–378. doi: 10.1212/wnl.39.3.373. [DOI] [PubMed] [Google Scholar]
  9. Gray J., Swaiman K. F. Brain tumors in children with neurofibromatosis: computed tomography and magnetic resonance imaging. Pediatr Neurol. 1987 Nov-Dec;3(6):335–341. doi: 10.1016/0887-8994(87)90004-x. [DOI] [PubMed] [Google Scholar]
  10. Halliday A. L., Sobel R. A., Martuza R. L. Benign spinal nerve sheath tumors: their occurrence sporadically and in neurofibromatosis types 1 and 2. J Neurosurg. 1991 Feb;74(2):248–253. doi: 10.3171/jns.1991.74.2.0248. [DOI] [PubMed] [Google Scholar]
  11. Huson S. M., Harper P. S., Compston D. A. Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales. Brain. 1988 Dec;111(Pt 6):1355–1381. doi: 10.1093/brain/111.6.1355. [DOI] [PubMed] [Google Scholar]
  12. Jackler R. K., Shapiro M. S., Dillon W. P., Pitts L., Lanser M. J. Gadolinium-DTPA enhanced magnetic resonance imaging in acoustic neuroma diagnosis and management. Otolaryngol Head Neck Surg. 1990 Jun;102(6):670–677. doi: 10.1177/019459989010200608. [DOI] [PubMed] [Google Scholar]
  13. Lekanne Deprez R. H., Groen N. A., van Biezen N. A., Hagemeijer A., van Drunen E., Koper J. W., Avezaat C. J., Bootsma D., Zwarthoff E. C. A t(4;22) in a meningioma points to the localization of a putative tumor-suppressor gene. Am J Hum Genet. 1991 Apr;48(4):783–790. [PMC free article] [PubMed] [Google Scholar]
  14. Lewis R. A., Gerson L. P., Axelson K. A., Riccardi V. M., Whitford R. P. von Recklinghausen neurofibromatosis. II. Incidence of optic gliomata. Ophthalmology. 1984 Aug;91(8):929–935. doi: 10.1016/s0161-6420(84)34217-8. [DOI] [PubMed] [Google Scholar]
  15. Lewis R. A., Riccardi V. M. Von Recklinghausen neurofibromatosis. Incidence of iris hamartomata. Ophthalmology. 1981 Apr;88(4):348–354. doi: 10.1016/s0161-6420(81)35034-9. [DOI] [PubMed] [Google Scholar]
  16. Martin G. A., Viskochil D., Bollag G., McCabe P. C., Crosier W. J., Haubruck H., Conroy L., Clark R., O'Connell P., Cawthon R. M. The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell. 1990 Nov 16;63(4):843–849. doi: 10.1016/0092-8674(90)90150-d. [DOI] [PubMed] [Google Scholar]
  17. Martuza R. L., Eldridge R. Neurofibromatosis 2 (bilateral acoustic neurofibromatosis). N Engl J Med. 1988 Mar 17;318(11):684–688. doi: 10.1056/NEJM198803173181106. [DOI] [PubMed] [Google Scholar]
  18. Menon A. G., Anderson K. M., Riccardi V. M., Chung R. Y., Whaley J. M., Yandell D. W., Farmer G. E., Freiman R. N., Lee J. K., Li F. P. Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis. Proc Natl Acad Sci U S A. 1990 Jul;87(14):5435–5439. doi: 10.1073/pnas.87.14.5435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. O'Connell P., Leach R., Cawthon R. M., Culver M., Stevens J., Viskochil D., Fournier R. E., Rich D. C., Ledbetter D. H., White R. Two NF1 translocations map within a 600-kilobase segment of 17q11.2. Science. 1989 Jun 2;244(4908):1087–1088. doi: 10.1126/science.2543077. [DOI] [PubMed] [Google Scholar]
  20. Orkin S. H. Reverse genetics and human disease. Cell. 1986 Dec 26;47(6):845–850. doi: 10.1016/0092-8674(86)90799-3. [DOI] [PubMed] [Google Scholar]
  21. Packer R. J., Sutton L. N., Bilaniuk L. T., Radcliffe J., Rosenstock J. G., Siegel K. R., Bunin G. R., Savino P. J., Bruce D. A., Schut L. Treatment of chiasmatic/hypothalamic gliomas of childhood with chemotherapy: an update. Ann Neurol. 1988 Jan;23(1):79–85. doi: 10.1002/ana.410230113. [DOI] [PubMed] [Google Scholar]
  22. Pearson-Webb M. A., Kaiser-Kupfer M. I., Eldridge R. Eye findings in bilateral acoustic (central) neurofibromatosis: association with presenile lens opacities and cataracts but absence of Lisch nodules. N Engl J Med. 1986 Dec 11;315(24):1553–1554. doi: 10.1056/NEJM198612113152419. [DOI] [PubMed] [Google Scholar]
  23. Pierce S. M., Barnes P. D., Loeffler J. S., McGinn C., Tarbell N. J. Definitive radiation therapy in the management of symptomatic patients with optic glioma. Survival and long-term effects. Cancer. 1990 Jan 1;65(1):45–52. doi: 10.1002/1097-0142(19900101)65:1<45::aid-cncr2820650111>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  24. Ponder B. A. Inherited predisposition to cancer. Trends Genet. 1990 Jul;6(7):213–218. doi: 10.1016/0168-9525(90)90181-5. [DOI] [PubMed] [Google Scholar]
  25. Riccardi V. M. Pathophysiology of neurofibromatosis. IV. Dermatologic insights into heterogeneity and pathogenesis. J Am Acad Dermatol. 1980 Aug;3(2):157–166. [PubMed] [Google Scholar]
  26. Rouleau G. A., Seizinger B. R., Wertelecki W., Haines J. L., Superneau D. W., Martuza R. L., Gusella J. F. Flanking markers bracket the neurofibromatosis type 2 (NF2) gene on chromosome 22. Am J Hum Genet. 1990 Feb;46(2):323–328. [PMC free article] [PubMed] [Google Scholar]
  27. Sarfarazi M., Huson S. M., Edwards J. H. An exclusion map for Von Recklinghausen neurofibromatosis. J Med Genet. 1987 Sep;24(9):515–520. doi: 10.1136/jmg.24.9.515. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Seizinger B. R., Rouleau G. A., Ozelius L. J., Lane A. H., Faryniarz A. G., Chao M. V., Huson S., Korf B. R., Parry D. M., Pericak-Vance M. A. Genetic linkage of von Recklinghausen neurofibromatosis to the nerve growth factor receptor gene. Cell. 1987 Jun 5;49(5):589–594. doi: 10.1016/0092-8674(87)90534-4. [DOI] [PubMed] [Google Scholar]
  29. Seizinger B. R., Rouleau G., Ozelius L. J., Lane A. H., St George-Hyslop P., Huson S., Gusella J. F., Martuza R. L. Common pathogenetic mechanism for three tumor types in bilateral acoustic neurofibromatosis. Science. 1987 Apr 17;236(4799):317–319. doi: 10.1126/science.3105060. [DOI] [PubMed] [Google Scholar]
  30. Viskochil D., Buchberg A. M., Xu G., Cawthon R. M., Stevens J., Wolff R. K., Culver M., Carey J. C., Copeland N. G., Jenkins N. A. Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell. 1990 Jul 13;62(1):187–192. doi: 10.1016/0092-8674(90)90252-a. [DOI] [PubMed] [Google Scholar]
  31. Wallace M. R., Marchuk D. A., Andersen L. B., Letcher R., Odeh H. M., Saulino A. M., Fountain J. W., Brereton A., Nicholson J., Mitchell A. L. Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science. 1990 Jul 13;249(4965):181–186. doi: 10.1126/science.2134734. [DOI] [PubMed] [Google Scholar]
  32. Ward K., O'Connell P., Carey J. C., Leppert M., Jolley S., Plaetke R., Ogden B., White R. Diagnosis of neurofibromatosis I by using tightly linked, flanking DNA markers. Am J Hum Genet. 1990 May;46(5):943–949. [PMC free article] [PubMed] [Google Scholar]
  33. Xu G. F., Lin B., Tanaka K., Dunn D., Wood D., Gesteland R., White R., Weiss R., Tamanoi F. The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae. Cell. 1990 Nov 16;63(4):835–841. doi: 10.1016/0092-8674(90)90149-9. [DOI] [PubMed] [Google Scholar]
  34. Zang K. D., Singer H. Chromosomal consitution of meningiomas. Nature. 1967 Oct 7;216(5110):84–85. doi: 10.1038/216084a0. [DOI] [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES